August 2021

In mid-July 2021, Pfizer, Inc. and two of its subsidiaries, Meridian Medical Technologies and King Pharmaceuticals, agreed to pay…

In mid-June, JAMA published a study that found that a majority of hospitals are not complying with the transparency rule finalized…

The controversial approval of Biogen’s Alzheimer’s drug, Aduhelm, has propelled investigations in at least two Congressional…

Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth…

Four years after the 21st Century Cures Act was signed into law, Reps. Diana DeGette (D-CO) and Fred Upton (R-MI) recently…

On July 21, 2021, New York Attorney General Letitia James announced a proposed $26 billion agreement with three drug distributors…

Recently, Abbott Laboratories agreed to pay $160 million to resolve claims that two of its units submitted false claims to…

On August 6, 2021, the Pharmaceutical Research and Manufacturers of America (PhRMA) released its updated Code on Interactions with…

On July 19, 2021, the American Society of Hematology (ASH) and 26 other organizations sent a letter to Graham McMahon, MD, MMSc,…

By Peter J. Pitts, Robert Popovian, and Wayne Winegarden What happens when regulatory ambiguity displaces sound…